•
Sep 30, 2020

Cencora Q4 2020 Earnings Report

AmerisourceBergen reported fourth quarter earnings with a revenue increase of 7.9% year-over-year and an adjusted diluted EPS increase of 17.4%.

Key Takeaways

AmerisourceBergen Corporation reported a 7.9% increase in revenue to $49.2 billion for the fourth quarter of fiscal year 2020. GAAP diluted EPS was $(23.74), while adjusted diluted EPS increased 17.4% to $1.89. The company recorded a $6.6 billion expense accrual related to opioid lawsuits.

Revenue increased 7.9% to $49.2 billion.

GAAP diluted EPS was $(23.74).

Adjusted diluted EPS increased 17.4% to $1.89.

The company recorded a $6.6 billion expense accrual related to opioid lawsuits.

Total Revenue
$49.2B
Previous year: $45.6B
+7.9%
EPS
$1.89
Previous year: $1.61
+17.4%
Effective Tax Rate
21.1%
Adjusted Effective Tax Rate
21.7%
Gross Profit
$1.35B
Previous year: $1.18B
+13.7%
Cash and Equivalents
$4.6B
Previous year: $3.37B
+36.3%
Free Cash Flow
$1.18B
Previous year: $593M
+99.0%
Total Assets
$43.9B
Previous year: $39.2B
+12.2%

Cencora

Cencora

Cencora Revenue by Segment

Forward Guidance

AmerisourceBergen introduced its fiscal year 2021 financial guidance, expecting revenue growth in the mid-single digit percent range and adjusted diluted earnings per share to be in the range of $8.20 to $8.45.

Positive Outlook

  • Revenue growth in the mid-single digit percent range.
  • Adjusted diluted earnings per share to be in the range of $8.20 to $8.45.
  • Adjusted operating expenses to increase in the mid-single digit percent range.
  • Adjusted operating income growth in the mid-single digit percent range.
  • Adjusted effective tax rate to be approximately 21 percent to 22 percent.

Revenue & Expenses

Visualization of income flow from segment revenue to net income